Phase i dose-escalation study of vb-111, an antiangiogenic virotherapy, in patients with advanced solid tumors

Authors
Publication date
20 September 2018
Publisher
'American Association for Cancer Research (AACR)'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Irish Universities

    redirect
    Last time updated on 18/04/2019